PALISADE CAPITAL MANAGEMENT, LP – Heron Therapeutics, Inc. Transaction History
PALISADE CAPITAL MANAGEMENT, LP portfolio value:
$14.3M
portfolio value
PALISADE CAPITAL MANAGEMENT, LP quarter portfolio value change:
+51.25%
quarter
Heron Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.32% | 424.55K shares | 6.03M | $4.22 | 3.38M |
| Q2 2022 | share | Increase | +1.47% | 42.96K shares | -8.43M | $2.79 | 2.96M |
| Q1 2022 | share | Decrease | -3.73% | -113.06K shares | -10.99M | $5.72 | 2.92M |
| Q4 2021 | share | Increase | +21.78% | 542.58K shares | 1.06M | $9.31 | 3.03M |
| Q3 2021 | share | Increase | +36.97% | 672.45K shares | -1.59M | $10.69 | 2.49M |
| Q2 2021 | share | Increase | +71.01% | 755.39K shares | 10.99M | $15.52 | 1.81M |
| Q1 2021 | share | Increase | +19.44% | 173.11K shares | -1.60M | $16.21 | 1.06M |
| Q4 2020 | share | Increase | +8.54% | 70.07K shares | 6.69M | $21.17 | 890.61K |
| Q3 2020 | share | Increase | +21.50% | 145.17K shares | 2.22M | $14.82 | 820.53K |
| Q2 2020 | share | Increase | +0.76% | 5.12K shares | 2.06M | $14.71 | 675.36K |
| Q1 2020 | share | Increase | +12.61% | 75.04K shares | -6.11M | $11.74 | 670.23K |
| Q4 2019 | share | Increase | +10.05% | 54.37K shares | 3.98M | $23.5 | 595.19K |
| Q3 2019 | share | Increase | +6.58% | 33.39K shares | 572K | $18.5 | 540.81K |
| Q2 2019 | share | Increase | +31.89% | 122.68K shares | 30K | $18.59 | 507.42K |
| Q1 2019 | share | Increase | +26.72% | 81.13K shares | 1.52M | $24.44 | 384.74K |
| Q4 2018 | share | Increase | 0.00% | 303.60K shares | 7.87M | $25.94 | 303.60K |